{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/2051433317031809536.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1007/s10157-019-01825-3"}},{"identifier":{"@type":"URI","@value":"http://id.ndl.go.jp/digimeta/11659180"}},{"identifier":{"@type":"URI","@value":"https://dl.ndl.go.jp/pid/11659180"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s10157-019-01825-3.pdf"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s10157-019-01825-3/fulltext.html"}},{"identifier":{"@type":"PMID","@value":"31823130"}}],"dc:title":[{"@value":"Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad : a novel selective urate reabsorption inhibitor"}],"dcterms:alternative":[{"@value":"Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad : a novel selective urate reabsorption inhibitor"}],"dc:language":"en","description":[{"notation":[{"@value":"収集根拠 : オンライン資料収集制度"},{"@value":"資料形態 : テキストデータ"},{"@value":"コレクション : 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/2061433317031809536","@type":"Researcher","foaf:name":[{"@value":"Hiroyuki Fukase"}]},{"@id":"https://cir.nii.ac.jp/crid/2061433317031809537","@type":"Researcher","foaf:name":[{"@value":"Daisuke Okui"}]},{"@id":"https://cir.nii.ac.jp/crid/2061433317031809538","@type":"Researcher","foaf:name":[{"@value":"Tomomitsu Sasaki"}]}],"publication":{"publicationIdentifier":[{"@type":"ISSN","@value":"14377799"},{"@type":"LISSN","@value":"14377799"},{"@type":"PISSN","@value":"13421751"},{"@type":"EISSN","@value":"14377799"}],"prism:publicationName":[{"@value":"Clinical and experimental nephrology : official publication of the Japanese Society of Nephrology"}],"dc:publisher":[{"@value":"Springer Nature"}],"prism:publicationDate":"2019-12-10","prism:volume":"24(supplement1)","prism:startingPage":"17","prism:endingPage":"24"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"http://id.ndl.go.jp/digimeta/11659180"},{"@id":"https://dl.ndl.go.jp/pid/11659180"},{"@id":"https://link.springer.com/content/pdf/10.1007/s10157-019-01825-3.pdf"},{"@id":"https://link.springer.com/article/10.1007/s10157-019-01825-3/fulltext.html"}],"foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Uricosuric%20Agents","dc:title":"Uricosuric Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Uric%20Acid","dc:title":"Uric Acid"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Original%20Article","dc:title":"Original Article"},{"@id":"https://cir.nii.ac.jp/all?q=Benzothiazoles","dc:title":"Benzothiazoles"},{"@id":"https://cir.nii.ac.jp/all?q=Renal%20Insufficiency","dc:title":"Renal Insufficiency"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Glomerular%20Filtration%20Rate","dc:title":"Glomerular Filtration Rate"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1391975276373564544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pharmacological properties and clinical efficacy of dotinurad (URECE<sup>®</sup> tablets), a novel hypouricemic agent"},{"@language":"ja","@value":"新規尿酸降下薬ドチヌラド（ユリス<sup>®</sup>錠）の薬理学的特長及び臨床効果"},{"@value":"新薬紹介総説 新規尿酸降下薬ドチヌラド(ユリス錠)の薬理学的特長及び臨床効果"},{"@language":"ja-Kana","@value":"シンヤク ショウカイ ソウセツ シンキ ニョウサン コウカヤク ドチヌラド(ユリスジョウ)ノ ヤクリガクテキ トクチョウ オヨビ リンショウ コウカ"}]}],"dataSourceIdentifier":[{"@type":"NDL_SEARCH","@value":"oai:ndlsearch.ndl.go.jp:R100000039-I11659180"},{"@type":"CROSSREF","@value":"10.1007/s10157-019-01825-3"},{"@type":"OPENAIRE","@value":"doi_dedup___::3b521859fb7fb347ebc11ad51f797842"},{"@type":"CROSSREF","@value":"10.1254/fpj.20047_references_DOI_ByOjaREw0jWzfz61W02IG2t63bM"}]}